How many institutions held GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share in Q3 2023?

48 institutional investors reported GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share for Q3 2023. Use the holders table for investor-level position and value details.

GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC)

Q: What does CUSIP 38000Q102 represent in this 13F holders report?

CUSIP 38000Q102 is the security identifier for GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 38000Q102

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class: Equity / Common Stock, par value $0.001 per share
Total 13F shares: 34,726,628
Share change: -864,841
Total reported value: $52,083,531
Put/Call ratio: 8.9%
Price per share: $1.50
Number of holders: 48
Value change: -$1,381,303
Number of buys: 12
Number of sells: 28

Quarterly Holders Quick Answers

What is CUSIP 38000Q102?
CUSIP 38000Q102 identifies GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2023
Previous quarter: Q2 2023

Recent filing periods for CUSIP 38000Q102:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Institutional Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2023

As of 30 Sep 2023, GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 34,726,628 shares. The largest 10 holders included BVF INC/IL, Artal Group S.A., NEA Management Company, LLC, Octagon Capital Advisors LP, VANGUARD GROUP INC, AXA S.A., ACADIAN ASSET MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, BlackRock Inc., and GEODE CAPITAL MANAGEMENT, LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q3 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.